My point is that nobody knows until we get through P3, and once that data comes out, it'll be too late to get in or out.
****
The common numerator of all 6 is that all 6 received the highest dose of A2-73. Got nothing to do with serial breakfast and what not. You know that I know that, what I dont know is why you are pretending its anything other than that. All 6 have nothing in common other than the highest A2-73 doze.
The 32 all received a different dose to test tolerance and safety and surprise, surprise the highest dose showed the best performance. Btw different AD drugs responded in the same manner just with the difference that brains were swelling so they had to cancel the trial, not with our drug. A2-73 is not even that great because of its performance A 2-73 is great because its safe to use...!
If the 300 new AD will all be dozed in the same manner as the 6 super responders then we will see a positive readout overtaken Donzepil but a three double-digit margin.
My investment advice for you and anyone else interested: invest an amount one does not need to touch for 2 years and wait until end 2019 and smile. ;
Market Data 
Markets 
AI
